Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
KUALA LUMPUR / PERTH, Jan 30, 2020 - (ACN Newswire) - ASX-listed Holista CollTech (ASX:HCT, 'Holista') announced today a strong spike in demand in Malaysia for it all-natural disinfectant spray NatShield™ Sanitizer containing the powerful Path-Away® anti-microbial compound. The increased demand follows the recent outbreak of the deadly coronavirus originating in Wuhan, China.
| NatShield Natural Sanitizer |
Holista confirmed that since mid-January 2020 it had sold all NatShield™ Sanitizer in its inventory. Each bottle of NatShield™ Sanitizer contains 5% of Path-Away®, which is made from natural plant-based substances that have been approved for use by the U.S. Food and Drug of Authority and tested by World Health Organization (WHO) approved laboratories in numerous countries around the world.
Developed by Global Infection Control Consultants LLC (GICC LLC) based in South Carolina, USA, Path-Away® (www.path-away.com) is distributed in Malaysia by Holista as NatShield™ Sanitizer. Holista is the exclusive distributor of Path-Away® for the ASEAN region. ASEAN countries with confirmed cases of the coronavirus include Malaysia, Singapore, Thailand and Cambodia.
Based on requests from seven chains representing over 3,000 pharmacies in Malaysia, Holista has ordered 60,000 bottles of NatShield™ Sanitizer to be air-freighted to Malaysia from the U.S.A. by mid-February.
The novel coronavirus was first reported to WHO on 31 December 2019 and has been under investigation ever since. Countries with confirmed infections include the U.S.A., Canada, France, Australia, Japan, South Korea and Nepal.
The active substance in the spray weakens the cell walls of the virus, causing the infectious organisms to clump together, in the process killing themselves, almost instantly. The potent compound is environmentally safe with very low toxicity and hence is not harmful to humans and pets even if accidentally swallowed. It is free of alcohol and other potentially toxic chemicals.
It is approved for use by Malaysia's Ministry of Health, with special reference to the H1N1 virus - another coronavirus, similar to one in this outbreak which led to more than 70 deaths in 2009. It has also been approved by the Food and Safety Authority of New Zealand, and the New Zealand Environmental Protection Authority (EPA). It is approved by the United States Pharmacopeia (USP) and has undergone successful USP-51 testing as a disinfectant.
"This is not a drug. It acts by sanitising body parts. It had been consistently shown to be effective and safe to users and the environment in the most advanced biosafety laboratories in the world," said Dr Rajen Manicka, the CEO of Holista, headquartered in Kuala Lumpur, Malaysia and listed on the Australian Securities Exchange (ASX).
"NatShield™ Sanitizer was created to treat previously known coronaviruses. It can be used as a precautionary spray in crowded areas including public transport. Three to five sprays are all that is needed to disinfect hands, toilet seats, doorknobs, countertops and trolley bars, with efficacy lasting up to two hours. We plan to sell it in all infected ASEAN countries," he said.
Dr Arthur Martin, the President of GICC LLC (www.giccllc.com) said, "The Path-Away® formula has been proven in world-renowned laboratories including those working with WHO, to be able to kill over 170 deadly pathogens including previously existing forms of coronaviruses. Path-Away® is currently undergoing testing on the newly emerged coronavirus, designated as novel coronavirus 2019-nCoV. Dr Martin, a globally respected scientist and a member of the WHO's Stop Tuberculosis (T.B.) Board, had been previously nominated for the prestigious Kochon Prize for his work on T.B. "Humans of all ages can use Path-Away® with little or no risk of toxic effects. It retains its efficacy for hours even under extremes of temperature and is not corrosive and can be used even in sensitive installations," he said.
Contact: Corporate Affairs & Business Opportunities Dr Rajen Manicka: rajen.m@holistaco.com General Enquiries: enquiries@holistaco.com
Media and Investor Relations: WeR1 Consultants Pte Ltd Karishma Ailsinghani E: holista@wer1.net; T: +65 84792656
About Holista CollTech Ltd
Holista CollTech Ltd ("Holista") is a research-driven biotech company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. Headquartered in Perth and with extensive operations in Malaysia, the company is dedicated to delivering first-class natural ingredients and wellness products globally. Holista is a leader in the research of herbs and ingredients for the making of healthier food.
Listed on the Australian Securities Exchange ("ASX"), Holista researches, develops, manufactures and markets 'health-style' products to address the unmet and evolving needs of natural medicine. Holista's suite of ingredients, among other things, includes low-GI baked products, reduced-sodium salts, low-fat fried foods and low calories sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods. For more information, please refer to http://www.holistaco.com
Source: Holista CollTech Ltd Sectors: BioTech, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024 Apr 25, 2024 18:21 JST
| MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park Apr 25, 2024 17:45 JST
| GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series Apr 25, 2024 16:50 JST
| Toyota Exhibiting at Beijing Motor Show 2024 Apr 25, 2024 16:25 JST
| Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada Apr 25, 2024 11:10 JST
| UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh Apr 25, 2024 09:00 JST
| Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date Apr 24, 2024 17:19 JST
| MC and Denka Sign J/V Agreement in Fullerene Business Apr 24, 2024 17:02 JST
| Mitsubishi Motors Posts Record Sales in the Philippines in FY2023 Apr 24, 2024 13:56 JST
| NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance Apr 24, 2024 13:25 JST
| Fujitsu SX Survey reveals key success factors for sustainability Apr 23, 2024 10:25 JST
| Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions Apr 22, 2024 16:09 JST
| NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II Apr 22, 2024 15:09 JST
| Soft Space Launches the First and Only JCB Payment Gateway in Malaysia Apr 22, 2024 15:00 JST
| TOYOTA GAZOO Racing takes a one-two in Croatian thriller Apr 22, 2024 10:47 JST
| First-ever Mazda CX-80 Crossover SUV Unveiled in Europe Apr 19, 2024 13:50 JST
| Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces Apr 19, 2024 10:17 JST
| Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas Apr 18, 2024 17:01 JST
| Toyota Launches All-New Land Cruiser "250" Series in Japan Apr 18, 2024 13:39 JST
| Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan Apr 18, 2024 11:14 JST
|
More Latest Release >>
|